Cargando…

Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides

COVID-19 caused by SARS-CoV-2 corona virus has become a global pandemic. In the absence of drugs and vaccine, and premises of time, efforts and cost required for their development, natural resources such as herbs are anticipated to provide some help and may also offer a promising resource for drug d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhanjal, Jaspreet Kaur, Kumar, Vipul, Garg, Sukant, Subramani, Chandru, Agarwal, Shubhra, Wang, Jia, Zhang, Huayue, Kaul, Ashish, Kalra, Rajkumar Singh, Kaul, Sunil C., Vrati, Sudhanshu, Sundar, Durai, Wadhwa, Renu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188803/ https://www.ncbi.nlm.nih.gov/pubmed/34118289 http://dx.doi.org/10.1016/j.ijbiomac.2021.06.015

Ejemplares similares

Effect of Ashwagandha Withanolides on Muscle Cell Differentiation
por: Wang, Jia, et al.
Publicado: (2021)

Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and Mortaparib(Plus)
por: Kumar, Vipul, et al.
Publicado: (2021)

Wild type p53 function in p53(Y220C) mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence
por: Sundar, Durai, et al.
Publicado: (2019)

Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost
por: Kaur, Amandeep, et al.
Publicado: (2018)

Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives
por: Malik, Vidhi, et al.
Publicado: (2020)

Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
por: Garg, Sukant, et al.
Publicado: (2019)

Identification and Characterization of Mortaparib(Plus)—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2021)

Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1
por: Meidinna, Hazna Noor, et al.
Publicado: (2022)

A Low Dose Combination of Withaferin A and Caffeic Acid Phenethyl Ester Possesses Anti-Metastatic Potential In Vitro: Molecular Targets and Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2022)

Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts
por: Kaul, Sunil C., et al.
Publicado: (2016)

Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity
por: Grover, Abhinav, et al.
Publicado: (2012)

Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
por: Putri, Jayarani F., et al.
Publicado: (2019)

Mutant p53(L194F) Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to Mortaparib(Plus), a Multimodal Small Molecule Inhibitor
por: Elwakeel, Ahmed, et al.
Publicado: (2021)

Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
por: Malik, Vidhi, et al.
Publicado: (2021)

Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study
por: Malik, Vidhi, et al.
Publicado: (2021)

Caffeic acid phenethyl ester (CAPE) confers wild type p53 function in p53(Y220C) mutant: bioinformatics and experimental evidence
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2021)

Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of p53 in cancer cells harbouring wild type and p53(Ser46) mutant
por: Shefrin, Seyad, et al.
Publicado: (2022)

Water Extract of Ashwagandha Leaves Limits Proliferation and Migration, and Induces Differentiation in Glioma Cells
por: Kataria, Hardeep, et al.
Publicado: (2011)

Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction
por: Kaushik, Mahesh K., et al.
Publicado: (2017)

2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
por: Chaudhary, Anupama, et al.
Publicado: (2019)

Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2014)

Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS Signaling
por: Widodo, Nashi, et al.
Publicado: (2010)

Integration of conventional cell viability assays for reliable and reproducible read-outs: experimental evidence
por: Garg, Sukant, et al.
Publicado: (2018)

Ashwagandha Leaf Derived Withanone Protects Normal Human Cells Against the Toxicity of Methoxyacetic Acid, a Major Industrial Metabolite
por: Priyandoko, Didik, et al.
Publicado: (2011)

Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin
por: Wadhwa, Renu, et al.
Publicado: (2016)

Phosphatidylserine Exposed Lipid Bilayer Models for Understanding Cancer Cell Selectivity of Natural Compounds: A Molecular Dynamics Simulation Study
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2022)

CARF enrichment promotes epithelial–mesenchymal transition via Wnt/β-catenin signaling: its clinical relevance and potential as a therapeutic target
por: Kalra, Rajkumar S., et al.
Publicado: (2018)

Combinations of Ashwagandha Leaf Extracts Protect Brain-Derived Cells against Oxidative Stress and Induce Differentiation
por: Shah, Navjot, et al.
Publicado: (2015)

Efficacy of Different Concentrations of Withanolides in Ashwagandha Supplements for Insomnia and Enhancing Energy Level
por: Yang, Lujia, et al.
Publicado: (2022)

Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
por: Malik, Vidhi, et al.
Publicado: (2022)

Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells
por: Konar, Arpita, et al.
Publicado: (2011)

Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
por: Sari, Anissa Nofita, et al.
Publicado: (2020)

Rat Glioma Cell-Based Functional Characterization of Anti-Stress and Protein Deaggregation Activities in the Marine Carotenoids, Astaxanthin and Fucoxanthin
por: Afzal, Sajal, et al.
Publicado: (2019)

Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action
por: Wadhwa, Renu, et al.
Publicado: (2013)

Differential Activities of the Two Closely Related Withanolides, Withaferin A and Withanone: Bioinformatics and Experimental Evidences
por: Vaishnavi, Kirti, et al.
Publicado: (2012)

Correction: Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action
por: Wadhwa, Renu, et al.
Publicado: (2013)

Anti-Stress, Glial- and Neuro-Differentiation Potential of Resveratrol: Characterization by Cellular, Biochemical and Imaging Assays
por: Afzal, Sajal, et al.
Publicado: (2020)

Withasomniferol D, a New Anti-Adipogenic Withanolide from the Roots of Ashwagandha (Withania somnifera)
por: Lee, Bum Soo, et al.
Publicado: (2021)

Investigating 11 Withanosides and Withanolides by UHPLC–PDA and Mass Fragmentation Studies from Ashwagandha (Withania somnifera)
por: Girme, Aboli, et al.
Publicado: (2020)

Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
por: Yu, Yue, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s1ruva6h018cod0fjm6tjjnda8